News from BAT Research & Development
Recent tests conducted by scientists at British American Tobacco (BAT) show that, in stark contrast to cigarette smoke, vapour from the commercially available e-cigarette Vype ePen is less toxic to, and does not cause oxidative stress in, human lung cells.
In the largest study of its kind, scientists from British American Tobacco and Nicoventures have developed a test to examine vaping behaviour, and then applied it to inform their studies on e-cigarettes.
Against a backdrop of a growing number of e-cigarette users globally*, British American Tobacco (BAT) is leading efforts to develop and harmonise standards around vaping products to further reassure consumers of these products potential in reducing the harm from smoking.
The impact of e-cigarettes was recently explored in BBC's Horizon documentary, E-cigarettes: Miracle or Menace?, which concluded that e-cigarettes could benefit public health.